Literature DB >> 32258059

Finasteride Counseling for Male Androgenetic Alopecia Should Reflect Updated Findings on Prostate Cancer Risk.

Christine C Akoh1, Kumar Sukhdeo2.   

Abstract

Entities:  

Year:  2020        PMID： 32258059      PMCID： PMC7109384          DOI： 10.1159/000504893

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN： 2296-9160


× No keyword cloud information.
  10 in total

1.  Long-Term Effects of Finasteride on Prostate Cancer Mortality.

Authors:  Phyllis J Goodman; Catherine M Tangen; Amy K Darke; M Scott Lucia; Leslie G Ford; Lori M Minasian; Howard L Parnes; Michael L LeBlanc; Ian M Thompson
Journal:  N Engl J Med       Date:  2019-01-24       Impact factor: 91.245

2.  Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.

Authors:  Ian M Thompson; Chen Chi; Donna Pauler Ankerst; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2006-08-16       Impact factor: 13.506

3.  Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.

Authors:  Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Howard L Parnes; Scott M Lippman; Charles A Coltman
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

4.  Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.

Authors:  Joseph M Unger; Cathee Till; Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jason D Wright; William E Barlow; Scott D Ramsey; Lori M Minasian; Dawn L Hershman
Journal:  J Natl Cancer Inst       Date:  2016-08-26       Impact factor: 13.506

5.  Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).

Authors:  Jerry Shapiro; Keith D Kaufman
Journal:  J Investig Dermatol Symp Proc       Date:  2003-06

6.  Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.

Authors:  Mary W Redman; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Charles A Coltman; Ian M Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2008-05-18

7.  The influence of finasteride on the development of prostate cancer.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2003-06-24       Impact factor: 91.245

8.  Long-term survival of participants in the prostate cancer prevention trial.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; Howard L Parnes; Lori M Minasian; Paul A Godley; M Scott Lucia; Leslie G Ford
Journal:  N Engl J Med       Date:  2013-08-15       Impact factor: 91.245

9.  Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

Authors:  M Scott Lucia; Jonathan I Epstein; Phyllis J Goodman; Amy K Darke; Victor E Reuter; Francisco Civantos; Catherine M Tangen; Howard L Parnes; Scott M Lippman; Francisco G La Rosa; Michael W Kattan; E David Crawford; Leslie G Ford; Charles A Coltman; Ian M Thompson
Journal:  J Natl Cancer Inst       Date:  2007-09-11       Impact factor: 13.506

10.  A Comment on the Post-Finasteride Syndrome.

Authors:  Hudson Dutra Rezende; Maria Fernanda Reis Gavazzoni Dias; Ralph Michel Trüeb
Journal:  Int J Trichology       Date:  2018 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.